litlas
Log inCreate account

Peter J. Parker

Active 1978–2025

176
Papers
36,726
Citations
107
h-index
175
i10-index

Citations

Citations per year for Peter J. Parker1978: 2 citations1979: 4 citations1980: 5 citations1981: 2 citations1982: 18 citations1983: 28 citations1984: 26 citations1985: 45 citations1986: 64 citations1987: 183 citations1988: 177 citations1989: 151 citations1990: 169 citations1991: 187 citations1992: 283 citations1993: 287 citations1994: 405 citations1995: 322 citations1996: 345 citations1997: 316 citations1998: 385 citations1999: 514 citations2000: 478 citations2001: 476 citations2002: 507 citations2003: 472 citations2004: 389 citations2005: 329 citations2006: 338 citations2007: 370 citations2008: 330 citations2009: 333 citations2010: 336 citations2011: 258 citations2012: 259 citations2013: 223 citations2014: 187 citations2015: 156 citations2016: 173 citations2017: 192 citations2018: 137 citations2019: 451 citations2020: 450 citations2021: 390 citations2022: 346 citations2023: 227 citations2024: 334 citations2025: 185 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,456 citing papers, 36.7% of this breakdownUnited Kingdom: 1,457 citing papers, 12% of this breakdownGermany: 694 citing papers, 5.7% of this breakdownJapan: 607 citing papers, 5% of this breakdownChina: 574 citing papers, 4.7% of this breakdownCanada: 452 citing papers, 3.7% of this breakdownFrance: 433 citing papers, 3.6% of this breakdownItaly: 356 citing papers, 2.9% of this breakdownSwitzerland: 307 citing papers, 2.5% of this breakdownSpain: 237 citing papers, 2% of this breakdownAustralia: 234 citing papers, 1.9% of this breakdownNetherlands: 192 citing papers, 1.6% of this breakdown
0%36.7%Other 17.7%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology58.7%
  • Medicine27.4%
  • Immunology and Microbiology5.6%
  • Neuroscience4.6%
  • Agricultural and Biological Sciences0.9%
  • Chemistry0.7%
  • Other2.1%

Topics

  • Protein Kinase Regulation and GTPase Signaling8.5%
  • PI3K/AKT/mTOR signaling in cancer4.3%
  • Cellular transport and secretion4%
  • Receptor Mechanisms and Signaling2%
  • Cell Adhesion Molecules Research2%
  • Metabolism, Diabetes, and Cancer1.6%
  • Other77.6%

Coauthors

All papers

Open in search
  1. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

    Authors: Lewis Au, Emine Hatipoglu, Marc Robert de Massy, Kevin Litchfield, Gordon Beattie, Andrew Rowan, Désirée Schnidrig, R. Houston Thompson, Fiona Byrne, Stuart Horswell, Nicos Fotiadis, Steve Hazell, David Nicol, Scott T.C. Shepherd, Annika Fendler, Robert M. Mason, Lyra Del Rosario, Kim Edmonds, Karla Lingard, Sarah Sarker, Mary Mangwende, Eleanor Carlyle, Jan Attig, Kroopa Joshi, Imran Uddin, Pablo D. Becker, Mariana Werner Sunderland, Ayse U. Akarca, Ignazio Puccio, William Yang, Tom Lund, Kim Dhillon, Marcos Duran Vasquez, Ehsan Ghorani, Hang Xu, Charlotte Spencer, José I. López, Anna Green, Ula Mahadeva, Elaine Borg, Miriam Mitchison, David A. Moore, Ian Proctor, Mary Falzon, Lisa Pickering, Andrew J.S. Furness, James L. Reading, Roberto Salgado, Teresa Marafioti, Mariam Jamal‐Hanjani, Chris Abbosh, Kai‐Keen Shiu, John Bridgewater, Daniel Hochhauser, Martin Förster, Siow Ming Lee, Tanya Ahmad, Dionysis Papadatos-Pastos, Sam M. Janes, Peter Van Loo, Katey S.S. Enfield, Nicholas McGranahan, Ariana Huebner, Stephan Beck, Peter J. Parker, Henning Walczak, Tariq Enver, Robert E. Hynds, Ron Sinclair, Chi-wah Lok, Zoe Rhodes, David A. Moore, Reena Khiroya, Giorgia Trevisan, Peter Ellery, Mark Linch, Sebastian Brandner, Crispin T. Hiley, Selvaraju Veeriah, Maryam Razaq, Heather Shaw, G. Attard, Mita Afroza Akther, Cristina Naceur‐Lombardelli, Lizi Manzano, Maise Al-Bakir, Simranpreet Summan, Nnenna Kanu, Sophia Ward, Uzma Asghar, Emilia L. Lim, Faye Gishen, Adrian Tookman, Paddy Stone, Caroline Stirling, Nikki Hunter, Sarah Vaughan, Mary Mangwende, Lavinia Spain, Haixi Yan and 105 more - Cancer Cell 2021 cited by 256

  2. Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts

    Authors: Michele Bortolomeazzi, Mohamed Reda Keddar, Lucia Montorsi, Amelia Acha‐Sagredo, Lorena Benedetti, Damjan Temelkovski, Subin Choi, Nedyalko Petrov, Katrina Todd, Patty T. Wai, Johannes Kohl, Tamara Denner, Emma Nye, Robert Goldstone, Sophia Ward, Gareth A. Wilson, Maise Al Bakir, Charles Swanton, Susan John, James Miles, Banafshé Larijani, Victoria Kunene, Elisa Fontana, Hendrik‐Tobias Arkenau, Peter J. Parker, Manuel Rodriguez‐Justo, Kai-Keen Shiu, Jo Spencer, Francesca D. Ciccarelli - Gastroenterology 2021 cited by 147

  3. The Candida albicans toxin candidalysin mediates distinct epithelial inflammatory responses through p38 and EGFR-ERK pathways

    Authors: Spyridoula-Angeliki Nikou, Chunsheng Zhou, James S. Griffiths, Natalia K. Kotowicz, Bianca M. Coleman, Mary Green, David L. Moyes, Sarah L. Gaffen, Julian R. Naglik, Peter J. Parker - Science Signaling 2022 cited by 61

  4. A selective PIKfyve inhibitor blocks PtdIns(3,5)P2 production and disrupts endomembrane transport and retroviral budding

    Authors: Harold B.J. Jefferies, Frank T. Cooke, Parmjit Jat, Christine Boucheron, Tomonobu Koizumi, Masahiko Hayakawa, Hiroyuki Kaizawa, Takahide Ohishi, Paul Workman, Michael D. Waterfield, Peter J. Parker - EMBO Reports 2008 cited by 302

  5. TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control

    Authors: Jemma Gatliff, Daniel A. East, James Crosby, Rosella Abeti, Robert Harvey, William Craigen, Peter J. Parker, Michelangelo Campanella - Autophagy 2014 cited by 212

  6. EGFR oligomerization organizes kinase-active dimers into competent signalling platforms

    Authors: Sarah R. Needham, Selene K. Roberts, Anton Arkhipov, Venkatesh Mysore, Christopher J. Tynan, Laura C. Zanetti-Domingues, Eric T. Kim, Valeria Losasso, Dimitris Korovesis, Michael Hirsch, Daniel J. Rolfe, David T. Clarke, Martyn Winn, Alireza Lajevardipour, Andrew H. A. Clayton, Linda J. Pike, Michela Perani, Peter J. Parker, Yibing Shan, David E. Shaw, Marisa L. Martin-Fernandez - Nature Communications 2016 cited by 211

  7. Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer

    Authors: Lissete Sánchez‐Magraner, Juan Gumuzio, James Miles, Nicole Quimi, Purificación Martínez del Prado, María Teresa Abad-Villar, Fernando Pikabea, Laura Ortega, Carmen Etxezarraga, Salvador Martín‐Algarra, María D. Lozano, Mónica Saiz-Camin, Mikel Egurrola-Izquierdo, Inmaculada Barredo-Santamaría, Alberto Saiz-López, Jenifer Gómez-Mediavilla, Nerea Segues-Merino, María Aranzazu Juaristi-Abaunz, Ander Urruticoechea, Erica J. Geraedts, Kim van Elst, Niels Claessens, Antoîne Italiano, Christopher J. Applebee, Sandra del Castillo, Charles H. Evans, Fernando Aguirre, Peter J. Parker, Véronique Calleja - Journal of Clinical Oncology 2023 cited by 80

  8. Synthesis and Function of 3-Phosphorylated Inositol Lipids

    Authors: Bart Vanhaesebroeck, Sally J. Leevers, Khatereh Ahmadi, John F. Timms, Roy Katso, Paul C. Driscoll, Rüdiger Woscholski, Peter J. Parker, Michael D. Waterfield - Annual Review of Biochemistry 2001 cited by 1,511

  9. Protein Kinase C-β Dictates B Cell Fate by Regulating Mitochondrial Remodeling, Metabolic Reprogramming, and Heme Biosynthesis

    Authors: Carlson Tsui, Núria Martínez, Mauro Gaya, Paula Maldonado, Miriam Llorian, Nathalie Legrave, Merja Rossi, James I. MacRae, Angus J.M. Cameron, Peter J. Parker, Michael Leitges, Andreas Bruckbauer, Facundo D. Batista - Immunity 2018 cited by 127

  10. Beta 1-integrin–c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes

    Authors: Rachel Barrow‐McGee, Naoki Kishi, Carine Joffre, Ludovic Ménard, Alexia Hervieu, Bakhouche A. Bakhouche, Alejandro J. Noval, Anja Mai, Camilo Guzmán, Luisa Robbez‐Masson, Xavier Iturrioz, James Hulit, Caroline H. Brennan, Ian R. Hart, Peter J. Parker, Johanna Ivaska, Stéphanie Kermorgant - Nature Communications 2016 cited by 105

  11. Intramolecular and Intermolecular Interactions of Protein Kinase B Define Its Activation In Vivo

    Authors: Véronique Calleja, Damien Alcor, Michel S. Laguerre, Jongsun Park, Borivoj Vojnovic, Brian A. Hemmings, Julian Downward, Peter J. Parker, Banafshé Larijani - PLoS Biology 2007 cited by 308

  12. The PKC/NF-κB Signaling Pathway Induces APOBEC3B Expression in Multiple Human Cancers

    Authors: Brandon Leonard, Jennifer L. McCann, Gabriel J. Starrett, Leah Kosyakovsky, Elizabeth M. Luengas, Amy M. Molan, Michael B. Burns, Rebecca M. McDougle, Peter J. Parker, William L. Brown, Reuben S. Harris - Cancer Research 2015 cited by 139

  13. PKC and the control of localized signal dynamics

    Authors: Carine Rossé, Mark Linch, Stéphanie Kermorgant, Angus J.M. Cameron, Katrina Boeckeler, Peter J. Parker - Nature Reviews Molecular Cell Biology 2010 cited by 482

  14. Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric Inhibition

    Authors: Véronique Calleja, Michel S. Laguerre, Peter J. Parker, Banafshé Larijani - PLoS Biology 2009 cited by 250

  15. The architecture of EGFR’s basal complexes reveals autoinhibition mechanisms in dimers and oligomers

    Authors: Laura C. Zanetti-Domingues, Dimitris Korovesis, Sarah R. Needham, Christopher J. Tynan, Shiori Sagawa, Selene K. Roberts, Antonija Kuzmanic, Elena Ortíz-Zapater, Purvi Jain, Rob C. Roovers, Alireza Lajevardipour, Paul M.P. van Bergen en Henegouwen, George Santis, Andrew H. A. Clayton, David T. Clarke, Francesco Luigi Gervasio, Yibing Shan, David E. Shaw, Daniel J. Rolfe, Peter J. Parker, Marisa L. Martin-Fernandez - Nature Communications 2018 cited by 97

  16. Drug-resistant EGFR mutations promote lung cancer by stabilizing interfaces in ligand-free kinase-active EGFR oligomers

    Authors: Rashi Iyer, Sarah R. Needham, Ioannis Galdadas, Benjamin M. Davis, Selene K. Roberts, Rico C.H. Man, Laura C. Zanetti-Domingues, David T. Clarke, Gilbert O. Fruhwirth, Peter J. Parker, Daniel J. Rolfe, Francesco Luigi Gervasio, Marisa L. Martin-Fernandez - Nature Communications 2024 cited by 52

  17. Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress

    Authors: Miratul M. K. Muqit, Patrick M. Abou‐Sleiman, Adrian T. Saurin, Kirsten Harvey, Sonia Gandhi, Emma Deas, Simon Eaton, Martin Smith, Kerrie Venner, Antoni Matilla‐Dueñas, Daniel G. Healy, William P. Gilks, Andrew J. Lees, Janice L. Holton, Tamás Révész, Peter J. Parker, Robert J. Harvey, Nicholas Wood, David S. Latchman - Journal of Neurochemistry 2006 cited by 170

  18. Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

    Authors: Kevin Litchfield, Stacey Stanislaw, Lavinia Spain, Lisa L. Gallegos, Andrew Rowan, Désirée Schnidrig, Heidi Rosenbaum, Alexandre Harlé, Lewis Au, Samantha M. Hill, Zayd Tippu, Jennifer Thomas, Lisa Thompson, Hang Xu, Stuart Horswell, Aoune Barhoumi, Carol Jones, Katherine F. Leith, Daniel L. Burgess, Thomas B.K. Watkins, Emilia Lim, Nicolai J. Birkbak, Philippe Lamy, Iver Nordentoft, Lars Dyrskjøt, Lisa Pickering, Stephen Hazell, Mariam Jamal-Hanjani, Chris Abbosh, Kai‐Keen Shiu, John Bridgewater, Daniel Hochhauser, Martin Förster, Siow Ming Lee, Tanya Ahmad, Dionysis Papadatos-Pastos, Sam M. Janes, Peter Van Loo, Katey S.S. Enfield, Nicholas McGranahan, Ariana Huebner, Sergio A. Quezada, Stephan Beck, Peter J. Parker, Henning Walczak, Tariq Enver, Robert E. Hynds, Mary Falzon, Ian Proctor, Ron Sinclair, Chi-wah Lok, Zoe Rhodes, David Moore, Teresa Marafioti, Elaine Borg, Miriam Mitchison, Reena Khiroya, Giorgia Trevisan, Peter Ellery, Mark Linch, Sebastian Brandner, Crispin T. Hiley, Selvaraju Veeriah, Maryam Razaq, Heather Shaw, G. Attard, Mita Afroza Akther, Cristina Naceur‐Lombardelli, Lizi Manzano, Maise Al-Bakir, Simranpreet Summan, Nnenna Kanu, Sophia Ward, Uzma Asghar, Emilia Lim, Faye Gishen, Adrian Tookman, Paddy Stone, Caroline Stirling, Andrew Furness, Kim Edmonds, Nikki Hunter, Sarah Sarker, Sarah Vaughan, Mary Mangwende, Karla Pearce, Lavinia Spain, Scott T.C. Shepherd, Haixi Yan, Benjamin Shum, Eleanor Carlyle, Steve Hazell, Annika Fendler, Fiona Byrne, Nadia Yousaf, Sanjay Popat, Olivia Curtis, Gordon Stamp, Antonia Toncheva, Emma Nye and 82 more - Cell Reports 2020 cited by 77

  19. Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications

    Authors: Tanya Soliman, Daniel Keifenheim, Peter J. Parker, Duncan J. Clarke - The Journal of Cell Biology 2023 cited by 26

  20. Autophosphorylation sites on the epidermal growth factor receptor

    Authors: Julian Downward, Peter J. Parker, Michael D. Waterfield - Nature 1984 cited by 722

  21. Osmotic stress activates phosphatidylinositol-3,5-bisphosphate synthesis

    Authors: Stephen K. Dove, Frank T. Cooke, Michael R. Douglas, Lee G. Sayers, Peter J. Parker, Robert H. Michell - Nature 1997 cited by 469

  22. A genetically-encoded crosslinker screen identifies SERBP1 as a PKCε substrate influencing translation and cell division

    Authors: Silvia Martini, Khalil Davis, Rupert Faraway, Lisa Elze, Nicola Lockwood, Andrew W. Jones, Xiao Xie, Neil Q. McDonald, David J. Mann, Alan Armstrong, Jernej Ule, Peter J. Parker - Nature Communications 2021 cited by 31

  23. Specific Involvement of PKC-ε in Sensitization of the Neuronal Response to Painful Heat

    Authors: Paolo Cesare, Lodewijk V. Dekker, Alessandro Sardini, Peter J. Parker, Peter A. McNaughton - Neuron 1999 cited by 409

  24. Svp1p defines a family of phosphatidylinositol 3,5‐bisphosphate effectors

    Authors: Stephen K. Dove, Robert C. Piper, Robert McEwen, Jong W. Yu, Megan C. King, David C. Hughes, Jan Willem Thuring, Andrew B. Holmes, Frank T. Cooke, Robert H. Michell, Peter J. Parker, Mark A. Lemmon - The EMBO Journal 2004 cited by 365